Originally published Thursday, January 7, 2010 at 5:55 AM
Comments (0)
E-mail article
Print
Share
Pfizer enters melanoma partnership with Debiopharm
Pfizer Inc. said Thursday it is reviving development of its melanoma drug tremelimumab through a collaboration with Swiss drugmaker Debiopharm Group.
The Associated Press
Pfizer Inc. said Thursday it is reviving development of its melanoma drug tremelimumab through a collaboration with Swiss drugmaker Debiopharm Group.
Financial terms of the deal were not disclosed, but the companies said Debiopharm will handle late-stage studies of tremelimumab, while Pfizer will handle marketing if it is approved. They said a biomarker will be selected to help identify the patients who are most likely to be helped be tremelimumab.
Melanoma is the deadliest form of skin cancer, and the number of melanoma cases worldwide is increasing faster than any other cancer, Pfizer said.
Pfizer ended a previous late-stage trial of the drug in April 2008 after a review of clinical data showed it was not much more effective than standard chemotherapy drugs. If the companies can find a biomarker that is connected to better results, they may have a better chance of running a successful study.
UPDATE - 09:46 AM
Exxon Mobil wins ruling in Alaska oil spill case
UPDATE - 09:32 AM
Bank stocks push indexes higher; oil prices dip
UPDATE - 08:04 AM
Ford CEO Mulally gets $56.5M in stock award
UPDATE - 07:54 AM
Underwater mortgages rise as home prices fall
NEW - 09:43 AM
Warner Bros. to offer movie rentals on Facebook
More Business & Technology headlines...
Entertainment | Top Video | World | Offbeat Video | Sci-Tech
Open Houses
|
Find all open houses.
|
"Iron Man 3" kicks off a summer blockbuster season that will see hundreds of speeding, squealing, exploding, airborne, rolling and smoking vehicles in...
Post a comment
- No question: Russell Wilson's in charge now
- Amazon’s plan for giant spheres gets mixed reaction
- Man shot by FBI had ties to Boston bombing suspect
- Is Catholic Church taking over health care in Washington? | Danny Westneat
- Ex-Great Wolf Lodge lifeguard charged with rape of guest, 14
- Percy Harvin already impressing Seahawks teammates, coaches
- ‘The Hangover Part III’: a big headache | Movie review
- McNerney: Boeing will squeeze suppliers and cut jobs
- High-level Starbucks exec heads to Kohl’s
- Sinking Mariners lose sixth straight game; changes ahead?
- Is Catholic Church taking over health care in Washington? 292
- Official: Treasury played no role in IRS targeting 242
- Game thread: Mariners try to end trip with a win 218
- Podcast: Mariners season hits crucial point 141
- Mariners head home facing key decisions as losing streak hits six 125
- Businesses refuse service to gays 121
- Mariners shuffle lineup, put Bay at leadoff and Morse at No. 3 84
- View from Sacramento: David Stern deserves statue, thanks 81
- Police: 1 dead, 2 injured in attack in London 65
- Mariners routed by Angels again, 7-1 51
- Is Catholic Church taking over health care in Washington? | Danny Westneat
- Amazon’s plan for giant spheres gets mixed reaction
- Catholic schools update to compete with charter schools
- McNerney: Boeing will squeeze suppliers and cut jobs
- UW Medicine, Catholic health system to have ‘strategic affiliation’
- Doctors save Ohio boy by ‘printing’ an airway tube | Close-up
- China’s wealthy paying cash for Eastside luxury homes
- No question: Russell Wilson's in charge now
- deafReview gives a voice to deaf consumers
- Ex-Great Wolf Lodge lifeguard charged with rape of guest, 14
